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Abstract
Purpose: To investigate the risk factors for squamous-cell carcinoma of the conjunctiva (SCCC) and other eye cancers in the NIH-AARP 
Diet and Health Study.
Methods: We estimated incidence rates and associations with age, sex, race/ethnicity and ultraviolet radiation using Cox proportional 
hazards models.
Results: The incidence was 37.3 per 106 for all eye cancers (N = 178), 8.4 per 106 for SCCC (N = 40) and 28.9 per 106 for other eye 
  cancers (N = 138). For all eye cancers, the incidence was lower in women than in men (hazard ratio [HR] = 0.38, 95% CI: 0.26, 0.55) and 
in persons aged ≤60 years than those aged >60 years (HR = 0.51, 95% CI: 0.36, 0.72). The incidence was higher, but not statistically 
  significant, in those with an average net erythemal exposure >170 versus ≤170 (HR = 1.19, 95% CI: 0.88, 1.63) and lower in those residing 
at latitudes >35° versus ≤35° (HR = 0.81, 95% CI: 0.61, 1.09). The patterns were similar for SCCC in sex, age, race/ethnicity and average 
net   erythemal exposure, but not statistically significant. 
Conclusion: The incidence of all eye cancers was associated with male sex and older age. The same patterns were observed for SCCC. 
The associations reported here might be surrogates of exposure to ultraviolet radiation, although more follow-up is needed to obtain precise 
results.R
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Background
SCCC is a rare cancer of the ocular surface with an incidence rate that varies geographically from 0.02 per 100,000 in high latitude areas to 
3.5 per 100,000 at low latitudes near the Equator [1,2]. This positive correlation between SCCC incidence and latitude indicates that expo-
sure to ultraviolet radiation may play a role in the etiology of SCCC. The risk is higher in males than in females. This may be because men 
are more likely to have outdoor occupations, which are associated with a greater propensity for exposure to ultraviolet radiation [1,2]. The 
other known risk of SCCC is immunosuppression, which is associated with 10 times higher SCCC risk in persons due to human immunode-
ficiency infection (HIV) and post-transplant immunosuppression [3–8]. The association with HIV was first noted in Uganda [3], based on an 
HIV prevalence of 75% in SCCC patients admitted at a tertiary hospital, compared to an HIV prevalence of 19% in age- and sex-matched 
controls with other eye conditions attending the same hospital [3], and confirmed in other parts of Africa [3–7] and in the United States [9]. 
In the United States, SCCC risk in persons with HIV/AIDS was higher in persons aged ≥50 years, of Hispanic ethnicity and who resided 
in the southern low altitude states [9], but not route of HIV acquisition. Among the general population in the United States, using data from 
the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, the risk of SCCC was higher in males 
and in Whites and was correlated to ultraviolet radiation [1]. In the current study, we investigated the risk of SCCC and other eye cancers 
among healthy, older Americans using data from the National Institutes of Health (NIH)-AARP Diet and Health Study [10], who have a low 
prevalence of HIV/AIDS, to complement our knowledge of SCCC risk obtained from immunosuppressed persons.
Methods
Study population
We used data from the NIH-AARP Diet and Health Study [10]. Briefly, the NIH-AARP cohort comprises 566,401 individuals aged 50–71 
years recruited from six US states and two metropolitan areas. Participants provided baseline questionnaire data during 1995–1996 and 
annual questionnaires update home address and vital status. Individuals whose data were based on proxy respondents and self-reported 
cancer conditions were excluded from the current analysis for a cohort of 487,770 persons followed up for an average of 9.78 years per 
individual. Cancer diagnosis was documented through annual record linkage with state cancer registries. Cancer incidence was calculated 
by dividing the number of cancer cases by the total person-years of follow-up. Person-years of follow-up for each participant was calculated 
from the date of baseline registration to the date a participant moved out of the catchment area, died, developed eye cancer, or the last date 
of follow-up (31 December 2006) [10,11]. 
Eye and orbit cancers were defined according to the International Classification of Diseases (ICD-10) codes C69.0–C69.9 grouped into 
SCCC (C69.0) and other eye cancers (C69.1–69.9). Ultraviolet radiation exposure was estimated based on the average net erythemal 
exposure from National Aeronautics and Space Administration (NASA) Total Ozone Mapping Spectrometer (TOMS) according to the 
  residence of the participant at baseline [12]. The NASA TOMS database provides daily information on a noon-time ground-level erythemal 
estimate on a 1° latitude by 1.25° longitude grid [13]. Each participant was assigned a ground-level erythemal dose by linking the   census 
track centroid of the self-reported residence at baseline, closest to the point on the TOMS grid. Census tract of each participant was 
assigned by a computer program spatially on longitude and latitude coordinates on geocoding residential addresses. The actual addresses 
were not available to the investigators. The erythemal dose was averaged across all available measured days in the months of January 
and July between 1978–1993 and 1996–2005 [12,13]. In addition, state residence and latitude were used to measure ultraviolet radiation 
based on census tract location where the participant resided at baseline.
Institutional review boards at the National Cancer Institute approved the NIH-AARP Diet and Health Study, and all participants gave written 
informed consent to participate.R
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Statistical analysis
Analyses included all eye cancers, including primary (N = 155) and secondary cancers (N = 23, including 8 that were SCCC). As the 
secondary eye cancers appeared unrelated to the primary cancers, i.e. a random set of cancers, we decided to combine the primary and 
secondary eye cancers to improve statistical stability of the results. Our primary interest was to examine risk factors for SCCC, but the 
numbers were sparse, so we conducted analyses examining risk factors of SCCC, of other eye cancers and of both groups combined. 
Although it would have been preferable to examine associations across the linear range of variables, the data were somewhat sparse. 
We thus grouped age as ≤60 years and >60 years, average net erythemal exposure as ≤170 and >170 and latitude as ≤35° and >35° to 
improve statistical stability of our estimates. The cut-offs for these categories were at medians based on a priori decisions to capture maxi-
mum contrasts in between the groups. Crude incidence and HR with 95% confidence intervals (CI) of all eye cancers and subgroups were 
calculated using Cox proportional hazard regression. Incidence was age-adjusted to the US population in 2000 to compare our results to 
those of the US general population aged 50–74 years. We adjusted associations for age and sex, which have been consistently shown to 
be linked to SCCC risk. A two-sided P-value <0.05, without adjustment for multiple comparisons, was considered statistically significant. 
Analysis was performed using SAS version 9.1 (SAS Institute, Cary, NC). 
Results
A total of 178 incident eye cancer cases were identified in the cohort (N = 141 and N = 37 in males and females, respectively) (Table 1). 
Of these, 155 (87%) were primary eye cancers and 23 were secondary eye cancers. The antecedent cancers for the secondary eye 
  cancers were prostate (N = 9), skin (N = 4) or urinary (N = 3). There was no change in the patterns with the inclusion or exclusion of these 
cancers. Most cancers were identified in males (79%), in participants aged ≥60 years at baseline (77%) and in non-Hispanic whites (96%). 
No cancers were noted among Blacks, most likely because this group comprised only 3.9% of the cohort. Slightly over half (57%) of the 
cancers occurred in participants residing in California, Florida and North Carolina, although these regions comprised 60% of the cohort. 
Overall, the incidence of eye cancers was 37.3 per 106. The incidence was lower in women than in men (19.0 versus 50.7 per 106; 
HR = 0.38, 95% CI: 0.26, 0.55) and lower in participants aged 60 years or younger versus older participants (23.2 versus 46.3 per 106; 
HR = 0.51, 95% CI: 0.36, 0.72). The incidence was slightly elevated among individuals with an average net erythemal exposure >170 
  versus ≤170 (HR = 1.22, 95% CI: 0.89, 1.65), slightly decreased in individuals residing at latitude greater than 35° compared to those 
  residing at a latitude less than 35° (HR = 0.81, 95% CI: 0.60, 1.08). The age-adjusted incidence rate for all eye cancers was 7.02 per 105, 
and it was higher in males (9.73) than in females (3.04). 
A total of 40 eye cancers were SCCC (22%) and 138 were other eye cancers (78%) (Table 2). The incidence of SCCC was 8.4 per 106; for 
other eye cancers, it was 28.9 per 106. The patterns of incidence for SCCC and other eye cancers resembled those observed for all eye 
cancers combined with respect to sex, age, race/ethnicity, average net erythemal exposure, state of residence and latitude, but the results 
were not statistically significant for SCCC. For other eye cancers, the incidence was significantly lower in women than in men (13.3 vs. 40.0 
per 106; HR = 0.34, 95% CI: 0.22, 0.51) and higher in participants aged ≥60 years at baseline than those who were 60 years or younger 
(35.6 vs. 17.5 per 106; HR = 0.49, 95% CI: 0.33, 0.73). R
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Table 1:  Characteristics of the cohort population in the NIH-AARP Diet and Health Study and eye cancer cases
Cohort Eye Cancer Cases
Characteristics Person-
years
N (%) N (%) Crude 
Incidence 
(106)
Hazard Ratio 
(95% CI)
Adjusted Hazard 
Ratio (95% CI)*
Total 4,769,686 487,700 100 178 100 37.3
Sex
Male 2,820,412 290,770 59.6 141 79.2 50.7 Reference Reference
Female 1,949,274 196,930 40.4 37 20.8 19.0 0.38 (0.26, 0.55) 0.38 (0.27, 0.55)
Age, years
≤ 60 1,768,476 177,517 36.4 41 23.0 23.2 0.51 (0.36, 0.72) 0.51 (0.36, 0.73)
> 60 3,001,210 310,183 63.6 137 77.0 46.3 Reference Reference
Race/Ethnicity
White (non-Hispanic) 4,342,907 444,272 91.1 170 95.5 39.6 Reference Reference
Black (non-Hispanic) 188,492 19,204 3.9 0 0.0 N/A N/A N/A
Hispanic 93,398 9,375 1.9 4 2.3 42.8 1.10 (0.41, 2.95) 1.1 (0.41, 2.97)
Asian, Pacific Islander or 
American Indian/Alaska 
Native
79,996 8,104 1.7 2 1.1 25.0 0.64 (0.16, 2.58) 0.64 (0.16, 2.58)
Unknown 64,893 6,745 1.4 2 1.1 30.8 0.79 (0.20, 3.17) 0.82 (0.20, 3.32)
Latitude, degree
≤ 35 2,156,115 221,493 45.4 90 50.6 42.7 Reference Reference
> 35 2,613,571 266,207 54.6 88 49.4 33.7 0.81 (0.60, 1.08) 0.81 (0.61, 1.09)
Average net erythemal exposure
≤ 170 3,312,387 337,596 69.2 116 65.2 35.0 Reference Reference
> 170 1,457,299 150,104 30.8 62 34.8 43.9 1.22 (0.89, 1.65) 1.19 (0.88, 1.63)
State of residence
California 1,466,258 150,886 30.9 57 32.0 40.4 Reference Reference
Florida 1,005,607 103,632 21.3 45 25.3 44.7 1.15 (0.78, 1.70) 1.11 (0.75, 1.64)
Georgia 134,585 13,707 2.8 5 2.8 37.2 0.95 (0.38, 2.38) 0.99 (0.40, 2.47)
Louisiana 180,948 18,412 3.8 7 3.9 38.7 0.99 (0.45, 2.17) 1.01 (0.46, 2.22)
Michigan 244,057 24,747 5.1 5 2.8 20.5 0.53 (0.21, 1.31) 0.54 (0.22, 1.35)
North Carolina 395,738 40,200 8.2 16 9.0 40.4 1.04 (0.60, 1.80) 1.02 (0.59, 1.78)
New Jersey 608,434 62,131 12.7 21 11.8 34.5 0.88 (0.54, 1.46) 0.88 (0.53, 1.45)
Pennsylvania 734,059 73,985 15.2 22 12.4 30.0 0.77 (0.47, 1.25) 0.75 (0.46, 1.23)
*Adjusted for sex and ageR
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Table 2:  Characteristics SCCC and other eye cancers in the cohort population of the NIH-AARP Diet and Health Study
SCCC Other Eye Cancers 
Characteristics N (%) Crude 
Incidence 
(106)
Hazard Ratio 
(95% CI)
Adjusted  
Hazard Ratio 
(95% CI)*
N (%) Crude 
Incidence 
(106)
Hazard Ratio 
(95% CI)
Adjusted  
Hazard Ratio 
(95% CI)*
Total 40 100 8.4 138 100 28.9
Sex
Male 29 72.5 10.3 Reference Reference 112 81.2 40.0 Reference Reference
Female 11 27.5 5.6 0.55 (0.27, 1.10) 0.55 (0.28, 1.11) 26 18.8 13.3 0.34 (0.22, 0.51) 0.34 (0.22, 0.52)
Age, years
≤ 60 10 25.0 5.7 0.56 (0.27, 1.15) 0.57 (0.28, 1.16) 31 22.5 17.5 0.49 (0.33, 0.73) 0.50 (0.33, 0.74)
> 60 30 75.0 10.0 Reference Reference 107 77.5 35.6 Reference Reference
Race/Ethnicity
White (non-Hispanic) 37 92.5 8.5 Reference Reference 133 96.4 30.6 Reference Reference
Black (non-Hispanic) 0 0 0 N/A N/A 0 0 N/A N/A N/A
Hispanic 1 2.5 10.7 1.26 (0.17, 9.14) 1.27 (0.17, 9.21) 3 2.2 32.1 1.05 (0.33, 3.30) 1.06 (0.34, 3.33)
Asian, Pacific 
Islander or American 
Indian/Alaska Native
1 2.5 12.5 1.47 (0.20, 10.8) 1.48 (0.20, 10.8) 1 0.7 12.5 0.41 (0.06, 2.93) 0.41 (0.06, 2.92)
Unknown 1 2.5 15.4 1.82 (0.25, 13.2) 1.86 (0.26, 13.6) 1 0.7 15.4 0.50 (0.07, 3.60) 0.53 (0.07, 3.78)
Latitude, degree
≤ 35 19 47.5 8.8 Reference Reference 71 51.4 32.9 Reference Reference
> 35 21 52.5 8.0 0.91 (0.49, 1.70) 0.92 (0.49, 1.71) 67 48.6 25.6 0.78 (0.56, 1.09) 0.78 (0.56, 1.10)
Average net erythemal exposure
≤ 170 25 62.5 7.5 Reference Reference 91 65.9 27.5 Reference Reference
> 170 15 37.5 10.3 1.37 (0.72, 2.59) 1.34 (0.71, 2.55) 47 34.1 32.3 1.17 (0.83, 1.67) 1.15 (0.81, 1.64)
State of residence
California 16 40.0 10.9 Reference Reference 41 29.7 28.0 Reference Reference
Florida 9 22.5 8.9 0.82 (0.36, 1.84) 0.79 (0.35, 1.80) 36 26.1 35.8 1.28 (0.82, 1.99) 1.23 (0.79, 1.93)
Georgia 0 0 0 N/A N/A 5 3.6 37.2 1.33 (0.52, 3.36) 1.38 (0.54, 3.49)
Louisiana 3 7.5 16.6 1.51 (0.44, 5.17) 1.53 (0.45, 5.26) 4 2.9 22.1 0.79 (0.28, 2.20) 0.81 (0.29, 2.25)
Michigan 3 7.5 12.3 1.11 (0.32, 3.82) 1.14 (0.33, 3.93) 2 1.5 8.2 0.29 (0.07, 1.21) 0.30 (0.07, 1.25)
North Carolina 3 7.5 7.6 0.69 (0.20, 2.36) 0.68 (0.20, 2.34) 13 9.4 32.9 1.17 (0.63, 2.19) 1.16 (0.62, 2.16)
New Jersey 3 7.5 4.9 0.45 (0.13, 1.54) 0.45 (0.13, 1.53) 18 13.0 29.9 1.06 (0.61, 1.84) 1.05 (0.60, 1.82)
Pennsylvania 3 7.5 4.1 0.37 (0.11, 1.27) 0.36 (0.11, 1.25) 19 13.8 25.9 0.92 (0.54, 1.59) 0.90 (0.52, 1.55)
*Adjusted for sex and ageR
e
s
e
a
r
c
h
 
A
r
ti
c
l
e
ecancer 2012, 6:254
  6  www.ecancer.org
Discussion
Our results are from the largest cohort study to date of mostly immune competent adults in the United States. Even so, the cases were 
sparse, highlighting the relatively low incidence of SCCC in particular and ocular cancers in general in the United States. Our SCCC find-
ings agree with those reported among immunosuppressed persons with HIV or transplantation indicating that risk of SCCC is higher among 
males, older individuals and individuals who reside at lower latitudes and experience high erythemal exposures. These associations have 
been interpreted as indicating a role of greater exposure to ultraviolet radiation in eye cancers, based mostly on studies conducted in 
Africa [3,4,6,14,15] and to a lesser extent on studies conducted in the United States [9] and in Australia [16,17]. An interesting, although 
not entirely surprising, finding is that the age-adjusted incidence rate for SCCC is lower in our study than in the comparable US population 
during 1998–2002. The incidences were 9.73 and 3.04 per 105 for males and females, respectively, in our study and 11.5 and 7.7 per 105 for 
males and females, respectively, in the United States [18]. The apparent difference in incidence may be an example of a healthy worker or 
a cohort effect. The NIH-AARP cohort is comprised mostly of individuals from a higher socioeconomic status in the United States whose risk 
of cancer may be lower than that of the US general population. Alternatively, the NIH AARP cohort may comprise individuals whose aver-
age exposure to solar ultraviolet radiation, which is considered the most likely biological risk factor for SCCC [1,19,20] and/or prevalence 
of immunosuppression due to HIV/AIDS, is lower than the general population. 
Our study has limitations, notably including the small number of cases accrued thus far. This limited our statistical power to detect new 
associations, particularly across the linear range of exposures, and to conduct subgroup analyses. The number of SCCC cases was small, 
which compelled us to combine primary and secondary cancers to increase statistical stability. This should be considered when interpreting 
our results. Our study provides no new insights on the interaction between immunosupression and solar ultraviolet radiation in the etiology 
of SCCC. Understanding the biological basis for the interaction would be useful for prevention, screening and early treatment to reduce 
morbidity for SCCC in populations at risk. Future work is needed to expand the number of cases available from representative populations 
with prospective data of high quality, including residence and solar ultraviolet radiation exposure, to obtain sound conclusions about the 
risk factors of SCCC.
Conclusions
To conclude, eye cancers including SCCC are rare with incidence associated with males, older age and residing at lower latitude or 
high erythemal exposures areas complementary to previous studies. These characteristics might be surrogates of exposure to ultraviolet 
  radiation.
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